Investor Relations
Pressemitteilungen
Quelle: MFN. Pressemitteilungen auf Englisch.
NOSA announces that MDR certificates have been issued for Nozoil
Nosa Plugs AB (publ) (“NOSA” or the “Company”) announces that MDR certificates have been issued for Nozoil® Nasal Spray Original and Nozoil® Nasal Spray Menthol. The products are Class IIa medical devices. The certificates were issued on 5
Nosa Plugs AB Interim Report for the Third Quarter 2026
This English version is a translation of the Swedish quarterly report of Nosa Plugs AB (publ). In the event of any discrepancies, the Swedish version shall prevail. Financial performance 1 July - 30 September 2026 Net sales 10,232 TSEK (3,6
NOSA signs agreement with SEDA S.p.A. and strengthens its presence in the Italian healthcare market
Nosa Plugs AB (publ) has today, through its subsidiary NoseOption AB (“NOSA” or the “Company”), entered into a distribution agreement with Italian company SEDA S.p.A. (“SEDA”) for the sale of NOSA Odor control, NOSA Microbial control and NO
NOSA signs agreement with Galls and launches NOSA Odor Control in the U.S.
Nosa Plugs AB (publ) (“NOSA” or the “Company”) has entered into a distribution agreement with U.S.-based Galls, LLC, for the sale of NOSA Odor Control in the United States. The agreement has been entered into through NOSA’s U.S. subsidiary,
NOSA signs agreement with distributor in Morocco
Nosa Plugs AB (“NOSA” or the “Company”) has entered into an exclusive distribution agreement with the Moroccan pharmaceutical company POLYMEDIC Co., Ltd (“Polymedic”) for the sale of Nozoil Original and Nozoil Menthol in the Moroccan market
NOSA signs exclusive distribution agreement in New Zealand with Tennex Health & Hygiene
Nosa Plugs AB (publ) has entered into an exclusive distribution agreement with the New Zealand-based group Tennex Health & Hygiene for the New Zealand market. This agreement replaces the previous partnership with CH2 (Clifford Hallam Health
Nosa Plugs AB Interim Report for the Second Quarter 2026
This English version is a translation of the Swedish quarterly report of Nosa Plugs AB (publ). In the event of any discrepancies, the Swedish version shall prevail. Financial Performance 1 April - 30 Juni 2026 Net sales: 8,843 TSEK (4,873)
NOSA enters into exclusive distribution agreement with MetroMed for five Middle Eastern markets
Nosa Plugs AB (publ) (“NOSA”) today announces that the Company has entered into an exclusive distribution agreement with MetroMed regarding the sale of NOSA’s full product portfolio in the United Arab Emirates, Kuwait, Qatar, Oman and Bahra
NOSA launches on the pharmacy market in the Netherlands and Belgium – receives order worth approximately SEK 1.4 million
NOSA has entered into a partnership with distributor OTC Health & Beauty regarding the company's products Nozoil and Odor Control for the markets in the Netherlands and Belgium. The order value amounts to approximately SEK 1.4 million a
NMD advances launch of Nozoil to Norwegian pharmacies and places additional order
The wholesaler Norsk Medisinaldepot (NMD), which recently added Nozoil to its range for sale in the Norwegian pharmacy market, announces today that the launch to pharmacies is being brought forward to June 1. In connection with the launch,
Nosa Plugs AB Interim Report for the First Quarter of 2026
This English version is a translation of the Swedish quartaly report of Nosa Plugs AB (publ). In the event of any discrepancies, the Swedish version shall prevail. CEO statement The year has started at a high pace, and we continue to exceed
Communiqué from the Annual General Meeting of Nosa Plugs AB (publ) held on 8 May 2026
The shareholders of Nosa Plugs AB (publ) held the Annual General Meeting at the company’s premises on Friday, 8 May 2026. Below is a summary of the most important resolutions adopted at the meeting.
NOSA appoints new distributor and launches Nozoil at Vitusapotek and Ditt Apotek in Norway
NOSA today announces that the company has initiated a cooperation and received an order from the Norwegian pharmaceutical wholesaler Norsk Medisinaldepot (NMD). The collaboration relates to the product Nozoil in the Norwegian market.
Nosa Plugs publishes Annual Report for 2025.
Nosa Plugs AB’s Board of Directors announces that the Annual Report for 2025 is now available on the company’s website: www.nosaplugs.com .
NOSA launches full consumer assortment in french pharmacy market
NOSA today announces the launch of its full consumer product portfolio in the French pharmacy market through an agreement with Phoenix OCP SAS (“OCP”), the French subsidiary of PHOENIX Group – one of Europe’s leading pharmaceutical distribu
NOSA Launches Nozoil in Austria Together with PHOENIX
Today, NOSA Nozoil is being launched in the Austrian pharmacy market together with PHOENIX AT (“PHOENIX”), one of the country’s leading pharmaceutical wholesalers.
Nosa Plugs AB Year End Report 2025
CEO statement
NOSA Receives Positive Organ Data from In Vivo Study on Drug Delivery
Researchers at Lund University have published a scientific report showing that NOSA’s intranasal drug delivery platform, Drug Delivery, achieves therapeutic levels of pharmaceuticals in the brain. The results indicate that NOSA Drug Deliver